IO Biotech, Inc. Diluted Shares Outstanding (Weighted Average)

IO Biotech, Inc. Diluted Shares Outstanding (Weighted Average)

IO Biotech, Inc. reported Diluted Shares Outstanding (Weighted Average) of 66.94 million shares for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2025-11-14

• IO Biotech, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 66.94M shares, a 1.61% increase year-over-year.
• IO Biotech, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 65.88M shares, a 0.00% change year-over-year.
• IO Biotech, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 65.88M shares, a 0.00% change year-over-year.
• IO Biotech, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-12-31 was 65.88M shares, a 0.37% decline year-over-year.
• IO Biotech, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 65.88M shares, a 51.31% increase from fiscal 2023.
• IO Biotech, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 43.54M shares, a 51.10% increase from fiscal 2022.
• IO Biotech, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 28.82M shares, a 564.62% increase from fiscal 2021.
• IO Biotech, Inc. weighted average number of shares outstanding, diluted for fiscal 2021 was 4.34M shares.